Attention Deficit Disorder With Hyperactivity Clinical Trial
Official title:
Organizational Skills Treatment for ADHD Children
This study will evaluate the effectiveness of organizational skills training in improving organizational, time management, and planning difficulties in children with attention deficit hyperactivity disorder.
Attention deficit hyperactivity disorder (ADHD) is one of the most common mental disorders
among children. Children with ADHD frequently lack organizational, time management, and
planning skills. These deficits can cause impaired functioning in multiple settings,
including home, school, and peer relationships. Advancements in treatment options for these
deficits, however, have been minimal. Previous research has indicated that organizational
skills training (OST) is an effective intervention for improving organizational skills in
children with ADHD. Its effectiveness relative to other available treatments is unknown.
This study will compare the effectiveness of OST with that of contingency management (CM)
and a waitlist condition in improving organizational, time management, and planning skills
deficits in children with ADHD.
Participants in this study are randomly assigned to OST, CM, or Wait-List (WL). Participants
in the OST and CM groups attend 20 1-hour sessions over 10 weeks. OST trains children to use
a variety of techniques for improving their organizational skills. Both children and their
parents attend every OST session. CM does not involve skills training. Rather, CM trains
parents and teachers to identify desired "end" behaviors and to increase the frequency of
these behaviors through the use of a structured reward system. Both children and their
parents attend every CM session, but the children's participation will be minimal.
Participants assigned to the waitlist condition will have the opportunity to receive their
choice of either OST or CM once they have completed the study. All participants attend
follow-up visits 1 month post-treatment. Participants assigned to OST and CM attend
follow-up visits after 1 and 4 months into their next school grade. School performance,
feelings about school, ADHD symptoms, organizational skills, family environment, medication
or services received, and use of treatment strategies will be assessed at each follow-up
visit.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00202605 -
Safety and Efficacy of SPD465 in Adults With ADHD
|
Phase 2 | |
Not yet recruiting |
NCT02677519 -
A 12-Month Open Label Safety Study of Aptensio XR® in Children Ages 4-5 Years Diagnosed With ADHD
|
Phase 4 | |
Completed |
NCT02730572 -
Concerta (Methylphenidate) -To-Generic Switch Study
|
N/A | |
Completed |
NCT01681082 -
Psychological Effects of Tai Chi Training
|
N/A | |
Active, not recruiting |
NCT01330693 -
Cortical Excitability: Phenotype and Biomarker in Attention-deficit, Hyperactivity Disorder (ADHD) Therapy
|
Phase 3 | |
Completed |
NCT00830700 -
Children's Attention Deficit Disorder With Hyperactivity (ADHD) Telemental Health Treatment Study
|
N/A | |
Completed |
NCT01012622 -
An Efficacy and Safety Study of Osmotic Release Oral System (OROS) Methylphenidate in Participants With Attention Deficit Hyperactivity Disorder (ADHD)
|
Phase 4 | |
Completed |
NCT00626236 -
Phase 2a Study of Safety and Tolerability of SPN-810 in Children With ADHD and Persistent Serious Conduct Problems
|
Phase 2 | |
Completed |
NCT00598182 -
Adherence and Long-term Effect of OROS Methylphenidate (CONCERTA): A Follow-up Study
|
N/A | |
Completed |
NCT00247572 -
Safety, Tolerability and Abuse Liability Study of Intravenous NRP104 in Adults With Stimulant Abuse Histories
|
Phase 2 | |
Completed |
NCT00178503 -
Methylphenidate for Attention Deficit Hyperactivity Disorder and Autism in Children
|
Phase 2/Phase 3 | |
Completed |
NCT00118911 -
Cognitive Behavioral Therapy for Treatment of Adult Attention Deficit Hyperactivity Disorder
|
N/A | |
Completed |
NCT00557011 -
NRP104, Adderall XR or Placebo in Children Aged 6-12 Years With ADHD
|
Phase 2 | |
Completed |
NCT00218322 -
Effectiveness of ATMX in Treating Adolescents With ADHD and SUD
|
Phase 4 | |
Completed |
NCT00071656 -
Psychosocial Treatment for Attention Deficit Hyperactivity Disorder (ADHD) Type I
|
N/A | |
Active, not recruiting |
NCT00057668 -
Preventing Behavior Problems in Children With ADHD
|
Phase 2 | |
Completed |
NCT00050622 -
Behavioral Treatment, Drug Treatment, and Combined Treatment for Attention Deficit Hyperactivity Disorder (ADHD)
|
N/A | |
Completed |
NCT00050050 -
Cognitive Behavioral Therapy for Adult Attention Deficit Hyperactivity Disorder
|
Phase 1 | |
Completed |
NCT00031395 -
Clonidine in Attention Deficit Hyperactivity Disorder (ADHD) in Children
|
Phase 3 | |
Completed |
NCT00000388 -
Multimodal Treatment Study of Children With Attention Deficit and Hyperactivity Disorder (MTA)
|
Phase 4 |